Executive Director, Clinical Development
Moderna, Inc.
Disclosure(s): Moderna, Inc.: Employee, Stocks/Bonds (Private Company)
Frances Priddy is Executive Director, Clinical Development and clinical lead for COVID-19 vaccines at Moderna. She is an infectious disease physician and leader in vaccine development, clinical strategy and infectious diseases with specific expertise in viral vaccines, biologics and maternal and child health. Passionate about leading teams to address the most critical global health needs through scientific innovation, collaboration and prevention.